Barr Seasonale Yields Similar Total Days Of Breakthrough Bleeding As Standard Oral Contraceptives
This article was originally published in The Pink Sheet Daily
Executive Summary
Intermenstrual bleeding rate was a key issue during FDA’s review of the extended-cycle oral contraceptive. Labeling warns about increased rate of intermenstrual bleeding and suggests it should be weighed against convenience of fewer planned menses.